Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. NUTROPINAQ (somatropine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

NUTROPINAQ (somatropine)

Medicine - Posted on Oct 03 2019
Active substance (DCI)
  • somatropine
history (5)
  • 9/18/19

    NUTROPINAQ (somatropine)

    Avis favorable au maintien du remboursement dans le traitement du déficit en hormone de croissance chez l’adulte ...
    icône flèche
  • 1/21/15

    NUTROPINAQ (somatropine)

    NUTROPINAQ (somatropine)
    icône flèche
  • 10/3/12

    NUTROPINAQ

    -
    icône flèche
  • 12/7/11

    NUTROPINAQ

    Maintien de l’avis favorable au remboursement chez l’enfant non déficitaire en hormone de croissance Progrès thérapeutique m...
    CAV :
    54321
    icône flèche
  • 9/15/04

    NUTROPINAq 10 mg / 2 ml, solution injectable en cartouche (boîte de 1)

    NUTROPINAq 10 mg / 2 ml, solution injectable en cartouche (boîte de 1)
    icône flèche
Technical information
ATC code
  • H01AC01
Manufacturer
IPSEN PHARMA
Presentation

NUTROPINAQ 10 mg/2 ml (30 UI), solution injectable (code CIS : 61968442)
1 cartouche(s) en verre de 2 ml - Code CIP : 34009 364 062 2 3
3 cartouche(s) en verre de 2 ml - Code CIP : 34009 274 192 4 9

All our publications
    Congenital, genetic and rare diseases Drug therapy Endocrine system diseases Kidney diseases Musculoskeletal diseases - miscellaneous Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
BCj3bsge4D4nfE8E